Fintel reports that on April 20, 2026, UBS initiated coverage of Healthpeak Properties (NYSE:DOC) with a Neutral recommendation.
Analyst Price Forecast Suggests 15.38% Upside
As of April 16, 2026, the average one-year price target for Healthpeak Properties is $19.73/share. The forecasts range from a low of $16.16 to a high of $30.45. The average price target represents an increase of 15.38% from its latest reported closing price of $17.10 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Healthpeak Properties is 566MM, a decrease of 79.96%. The projected annual non-GAAP EPS is 0.30.
What is the Fund Sentiment?
There are 773 funds or institutions reporting positions in Healthpeak Properties. This is an decrease of 581 owner(s) or 42.91% in the last quarter. Average portfolio weight of all funds dedicated to DOC is 0.08%, an increase of 63.29%. Total shares owned by institutions decreased in the last three months by 12.64% to 664,384K shares. 
The put/call ratio of DOC is 0.22, indicating a bullish outlook.
What are Other Shareholders Doing?
Jpmorgan Chase holds 30,675K shares representing 4.41% ownership of the company. In its prior filing, the firm reported owning 28,237K shares , representing an increase of 7.95%. The firm decreased its portfolio allocation in DOC by 4.41% over the last quarter.
Fuller & Thaler Asset Management holds 29,648K shares representing 4.26% ownership of the company. In its prior filing, the firm reported owning 24,872K shares , representing an increase of 16.11%. The firm decreased its portfolio allocation in DOC by 0.52% over the last quarter.
Principal Financial Group holds 26,682K shares representing 3.84% ownership of the company. In its prior filing, the firm reported owning 26,985K shares , representing a decrease of 1.14%. The firm decreased its portfolio allocation in DOC by 15.95% over the last quarter.
Geode Capital Management holds 19,534K shares representing 2.81% ownership of the company. In its prior filing, the firm reported owning 19,411K shares , representing an increase of 0.63%. The firm decreased its portfolio allocation in DOC by 18.25% over the last quarter.
Invesco holds 18,299K shares representing 2.63% ownership of the company. In its prior filing, the firm reported owning 16,651K shares , representing an increase of 9.01%. The firm decreased its portfolio allocation in DOC by 10.19% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
